Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
ENDODIAB from Ukkel, company number BE0739902934, closed financial year 2025 with a result of € 119,474 after tax. For that financial year ENDODIAB recorded a gross margin of € 197,777 and equity of € 156,288. Compared with financial year 2024, the result moved from € 21,187 to € 119,474. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 9, 2026.
€ 156,288
▲ 73% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 119,474
▲ € 98,287 vs 2024
Profit after tax over the fiscal year.
€ 32,638
▼ 63% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 53,689 paid out
45 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 2,926
▼ 44% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 324,449
▼ 17% vs 2024
€ 65,609 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 1,687
▼ 47% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,668
▲ 48% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 130,122 | € 148,729 | € 146,182 | € 197,777 | ▲ 35% |
| Profit after taxes | € -115,651 | € 28,679 | € 21,187 | € 119,474 | ▲ € 98,287 |
| Equity | € 40,637 | € 69,316 | € 90,503 | € 156,288 | ▲ 73% |
| Total debts | € 791,140 | € 782,432 | € 692,466 | € 530,006 | ▼ 23% |
| Cash | € 30,650 | € 88,376 | € 87,163 | € 32,638 | ▼ 63% |
| Land & buildings | € 669,986 | € 635,436 | € 600,886 | € 566,336 | ▼ 6% |
| Retained profit | € 35,637 | € 64,316 | € 85,503 | € 151,288 | ▲ 77% |
| Dividend | € 0 | € 0 | € 0 | € 53,689 | |
| Bank debt | € 518,328 | € 454,365 | € 389,742 | € 324,449 | ▼ 17% |
| Balance sheet total | € 831,776 | € 851,747 | € 782,969 | € 686,294 | ▼ 12% |
Key figures of ENDODIAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to ENDODIAB?
What happened at ENDODIAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 119,474 (▲ € 98,287 vs 2024). Source: NBB ↗
- New establishment in Sint-Gillis (bij-Brussel). KBO
- Start of the company according to the CBE. KBO
In short
From € 115,651 loss in 2022 to € 119,474 profit in 2025.
Paid € 15,044 in corporate taxes since 2022.
Best year ever: 2025, with € 119,474 profit.
Paid out € 53,689 in dividends to the owners in total.
A new publication or filing at ENDODIAB? We notify you, reason included.
Follow ENDODIABDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Marina Boscolo
administrateur
Establishments
Establishment units
Physical locations of this company
Dodonéestraat 21
1180 Ukkel
Ierlandstraat 10
1060 Sint-Gillis (bij-Brussel)
Active since 20 December 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0739.902.934
- VAT number
- BE 0739.902.934
- Registered office
- Dodonéestraat 21, 1180 Ukkel
- Names & denominations
- ENDODIAB
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 December 2019
- Peppol
- Active · Active since 24 Aug 2026